- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03498872
Strategic Research Program 17 (VUB Funding)
Exercise and the Brain in Health & Disease: The Added Value of Human-Centered Robotics
Objectives: The main objectives are to determine neural dynamics during gait using electro-encephalography as well as brain sources and to investigate the attentional demand during walking in able-bodied individuals, and individuals with an amputation.
Materials & Methods: 6 able-bodied individuals conducted one experimental trial, and 6 unilateral transtibial and 6 unilateral transfemoral amputees performed 2 experimental trials; the first with the current and the second with a novel powered transtibial prosthesis, i.e. the Ankle Mimicking Prosthetic foot 4.0. Each experimental trial comprised 2 walking tasks; 6 and 2min treadmill walking at normal speed interspersed by 5min of rest. During 6min walking the sustained attention to response (go-no go) task, with measures reaction time and accuracy, was performed. Electro-encephalographic (EEG) data were gathered when subjects walked 2min. Motor-related cortical potentials and brain activity during gait are extracted using EEG.
Study Overview
Status
Intervention / Treatment
Detailed Description
Detailed description of the novel device:
The device mainly distinguishes itself from commercial prostheses thanks to its new type of actuation providing a compact and energy efficient solution to the challenge of ankle-foot actuation. This new actuation method consists of using springs, a servo motor and a locking mechanism, coupled with a sensory network providing intelligence to the robotic device. The AMPfoot 4.0 design is also based on previous research conducted on the AMP-Foot 2. However, it is important to note that in contrast with its preceding designs, the AMP-Foot 4.0 does not provide active propulsion at push-off.
During walking, the AMP-Foot 4.0 working principle is divided into two main logic sequences, i.e. the stance and the swing phase. These two phases are detected by analyzing gyroscope and acceleration measurements from an Inertial Measurement Unit chip. During the stance phase, the ankle performs a dorsi-flexing movement while a plantar-flexing torque is applied at the ankle. The person's gravitational potential energy is stored into elastic potential energy by means of the used spring. It is this spring that provides the plantar-flexing torque required at the ankle as reaction to the movement of the user. Due to the use of a locking system, the prosthesis can adapt its so-called zero torque rest point depending on the slope or stride length of the user. This provides adaptability and therefore greater comfort compared to prostheses with a fixed zero torque rest point. During the swing phase, the locking mechanism unlocks to free the ankle movement. Parallel springs external to the stance system are then activated to reset the foot to its initial position. From that moment, the device is ready for a new step.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Vlaams Brabant
-
Brussel, Vlaams Brabant, Belgium, 1050
- Vrije Universiteit Brussel
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Unilateral transfemoral amputees
- Unilateral transtibial amputees
- Able-bodied individuals
Exclusion Criteria:
- Children
- Functional k-level lower than 4 (Amputee has the ability for prosthetic ambulation that exceeds basic ambulation skills, exhibiting high impact, stress or energy levels)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Non-Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Able-bodied individuals
|
The control group included healthy subjects.
Comparisons were made between amputees and able-bodied individuals.
|
|
Experimental: Transtibial amputee
|
The novel prosthetic device, i.e.
AMPfoot 4.0, was tested during walking in amputees.
A dual-task was conducted and non-invasive electro-encephalography was used to investigate neural dynamics.
|
|
Experimental: Transfemoral amputee
|
The novel prosthetic device, i.e.
AMPfoot 4.0, was tested during walking in amputees.
A dual-task was conducted and non-invasive electro-encephalography was used to investigate neural dynamics.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Reaction time (in ms) of responses during go - no go cognitive task
Time Frame: Through study completion, a period of 2 months
|
Time between visual stimulus and motor response (pushing button)
|
Through study completion, a period of 2 months
|
|
Accuracy (in percentage) of correct responses during go - no go cognitive task
Time Frame: Through study completion, a period of 2 months
|
Accuracy of motor responses to visual stimuli
|
Through study completion, a period of 2 months
|
|
EEG extracted brain signals, i.e. motor-related cortical potentials
Time Frame: Through study completion, a period of 2 months
|
Non-invasive electro-encephalography was used to determine electro-cortical potentials and brain sources of these potentials
|
Through study completion, a period of 2 months
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PROJECT-ID SRP 17
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Prosthesis User
-
Liberating Technologies, Inc.Eunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedAmputation | Prosthesis | Prosthesis UserUnited States
-
University Medical Center GroningenZonMw: The Netherlands Organisation for Health Research and DevelopmentRecruitingAmputation | Prosthesis | Prosthesis UserNetherlands
-
University Medical Center GroningenZonMw: The Netherlands Organisation for Health Research and DevelopmentCompletedAmputation | Prosthesis | Prosthesis UserNetherlands
-
Liberating Technologies, Inc.Completed
-
Menoufia UniversityRecruiting
-
Mansoura UniversityCompleted
-
Medipol UniversityCompletedProsthesis UserTurkey (Türkiye)
-
University of Wisconsin, MilwaukeeCompleted
-
Hacettepe UniversityCompletedProsthesis User, DigitalismTurkey (Türkiye)
-
The Hong Kong Polytechnic UniversityCompletedAmputation | Prosthesis UserHong Kong
Clinical Trials on No intervention
-
Hopital FochNot yet recruitingInterstitial Lung DiseaseFrance
-
Wave NeuroscienceCompletedAutistic DisorderUnited States
-
University of Alabama at BirminghamCompletedInflammatory Bowel Diseases | Colorectal Cancer | Diverticular Diseases | Social BehaviorUnited States
-
Janssen Research & Development, LLCCompletedLupus Erythematosus, Systemic | Lupus Erythematosus, Cutaneous | Lupus Erythematosus, DiscoidUnited States, Poland
-
Hospital Universitario La Paz3MVX CCB and Agaplesion Markus Krankenhaus, Frankfurt a.M., Germany.; Department...RecruitingEmbolism | Atrial Fibrillation | Arrhythmia | Stroke, Acute | Stroke Sequelae | AblationSpain
-
Southern California College of Optometry at Marshall...Ohio State University; University of Houston; Alcon Research; University of Waterloo and other collaboratorsCompletedContact Lens Complication | Contact Lens Acute Red Eye | Contact Lens Related Corneal Infiltrate (Disorder) | Contact Lens-Induced Corneal Fluorescein StainingUnited States, Canada
-
Huashan HospitalZhejiang Cancer Hospital; Shanghai Zhongshan Hospital; Tongji Hospital; Qilu Hospital... and other collaboratorsRecruitingHead and Neck Squamous Cell Carcinoma | Patient Derived Organoid | Drug Sensitive Test in VitroChina
-
China Medical University HospitalUnknownIntention to Stay, Turnover Behavior
-
University of Dublin, Trinity CollegeCompleted